CD19-targeted HSP90 inhibitor nanoparticle combined with TKIs reduces tumor burden and enhances T-cell immunity in murine B-cell malignancies

Authors: Mengting Qin, Juan Ren, Xiaodong Chen, Wen Zhou, Shuyuan Zhang, Weile Zhang, Mengxin Shi, Mingzhen Zhang, Huashen Liu, Yunfeng Ma, Mei Yang, Yanhong Ji

Published: 2025-03-12

DOI: 10.7150/thno.106758

Source: Full article

---

Abstract

No abstract found.